BUFFALO, N.Y. — For decades, pharmacists and medical institutions have relied on the Cockcroft-Gault (C-G) estimated creatinine clearance assessment to determine medication dosing and treatment for ...

A new study published in the Journal American Medical Association showed that patients with an Cystatin C based estimated ...

Removing race from the eGFR was a long process that divided the field of nephrology for years. After a task force for the ...

At any given time almost 90,000 people in the United States are waiting for a kidney transplant, and every day 11 die waiting for one. Of these people, 35% are Black patients receiving dialysis for ...

The FDA accepted a Biologics License Application for imlifidase for the desensitization treatment of highly sensitized adult kidney transplant patients.

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

As healthcare systems advance precision diagnostics and risk stratification, integrating Cystatin C into routine practice is increasingly important. A measure of kidney function, Cystatin C ...

Thousands have been given credit on the waiting list for time lost ...

Higher drug exposure in women due to lower renal and hepatic clearance and body composition can increase efficacy but also toxicity, highlighting the need to reassess dosing.

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Diabetes is one of the leading causes of kidney disease worldwide, and India carries a particularly high burden of both conditions. What makes diabetic kidney disease especially concerning is that it ...